AI
DXCM icon

Axiom Investors’s DexCom DXCM Stock Holding History

Axiom Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-182,496
Closed -$16.4M – 127
2021
Q1 		$16.4M Sell
182,496
-265,128
-59% -$24.9M 0.3% 58
2020
Q4 		$41.4M Buy
447,624
+116,900
+35% +$10.4M 0.65% 43
2020
Q3 		$34.1M Buy
+330,724
New +$34.6M 0.55% 41
2016
Q2 		– Sell
-64,220
Closed -$1.09M – 146
2016
Q1 		$1.09M Sell
64,220
-90,776
-59% -$1.52M 0.03% 126
2015
Q4 		$3.17M Buy
154,996
+10,464
+7% +$218K 0.1% 81
2015
Q3 		$3.1M Sell
144,532
-134,416
-48% -$3M 0.1% 68
2015
Q2 		$5.58M Buy
278,948
+37,776
+16% +$663K 0.16% 72
2015
Q1 		$3.76M Buy
241,172
+112,612
+88% +$1.7M 0.1% 87
2014
Q4 		$1.77M Buy
+128,560
New +$1.57M 0.04% 120

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Axiom Investors's DXCM Position: Q2 2021 in Review

Axiom Investors sold out of DexCom (DXCM) in Q2 2021, closing a stake of 182,496 shares — an estimated $16.4M sold.

Axiom Investors first reported a position in DXCM in Q4 2014 and held it in 9 quarters. The position peaked at $41.4M in Q4 2020. 728 funds tracked by Wall St. Rank hold DXCM as of Q2 2021.

  • Axiom Investors reported no remaining DexCom position as of Q2 2021 after selling out during the quarter.
  • Axiom Investors sold 182,496 DexCom shares in Q2 2021, an estimated $16.4M.
  • Axiom Investors first reported a position in DexCom in Q4 2014 and held it in 9 quarters.
  • Axiom Investors's DexCom position peaked at $41.4M in Q4 2020.
  • 728 funds tracked by Wall St. Rank held DexCom as of Q2 2021.

Based on Axiom Investors's 13F filing for Q2 2021, filed 13 Aug 2021.